Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody Response to Pneumococcal Vaccines in Splenectomized Beta Thalassemia Major Patients
IRCT201110116660N3Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jul 2011
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of 23-valent pneumococcal polysaccharide vaccine and pneumococcal conjugate vaccine in pneumococcal disease, sponsored by Mazandaran University of Medical Sciences. Started Jul 2011; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccinepneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on IRCT201110116660N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201110116660N3.